© PR Newswire
21.01.2026
BDX
LISTED
NYSE
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
News Preview
The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systemsLE PONT-DE-CLAIX, France and BURGDORF, Switzerland, Jan. 21, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading d...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
ATHE
LISTED
NASDAQ
Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
News Preview
MELBOURNE, Australia and SAN FRANCISCO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued a letter to shareholders. ...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
JNJ
LISTED
NYSE
Johnson & Johnson reports Q4 and Full-Year 2025 results
News Preview
Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. “2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “Last year kicked off a new era of accelerated growth,...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
21.01.2026
LSTA
LISTED
NASDAQ
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
News Preview
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestones...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© Globe Newswire
21.01.2026
OCUL
LISTED
NASDAQ
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer
News Preview
Accomplished global commercial leader with deep expertise in retina drug launches...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
SKYE
LISTED
NASDAQ
Skye Bioscience to Present Poster at Keystone Obesity Conference
News Preview
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will present a poster at Keystone’s conference, Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
XCUR
LISTED
NASDAQ
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
News Preview
REDWOOD CITY, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it will present a poster at the upcoming 2026 Tandem Meetings | Transplantation & Cellular Therapy Meetings of the American Society for Transplantat...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
NTRA
LISTED
NASDAQ
Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication in npj Precision Oncology of the validation study for its Latitude tissue-free molecular residual disease assay (tfMRD) in colorectal cancer (CRC). The peer-reviewed publication builds upon data that was previously presented at the...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
GMAB
LISTED
CPH
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
21.01.2026
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC Pink:MDCE) Completes Marketing Content for First AI-Based Lifestyle App Ahead of Imminent Launch
News Preview
Milestone Achieved as Company Lays Foundation for a Broad Portfolio of AI-Based Lifestyle, Wellness, and Medical Applications in 2026 and Beyond MESA, ARIZONA / ACCESS Newswire / January 21, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) ("Medical Care Technologies" or the "Company"), a developer of AI-driven lifestyle, w...
Themefolio
Profiler
Peergroup
© Newsfile
21.01.2026
DTC
LISTED
CSE
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
News Preview
Montreal, Quebec--(Newsfile Corp. - January 21, 2026) - Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today announced an evolution of its corporate positioning to reflect its focus as a precision intracellular drug-delivery company advancing its proprietary Acc...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
SECT_B
LISTED
STO
TUM University Hospital adds pathology and ophthalmology to its Sectra enterprise imaging solution--boosts diagnostic efficiency for improved patient care
News Preview
LINKÖPING, Sweden, Jan. 21, 2026 /PRNewswire/ -- The university hospital TUM Klinikum Rechts der Isar (TUM Klinikum) in Germany expands its enterprise imaging solution from international medical imaging IT and cybersecurity company Sectra (STO: SECT B) by adding the modules for pathology and ophthalmology. This will provide their clinicians with t...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ACCESS Newswire
21.01.2026
REVB
LISTED
NASDAQ
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
News Preview
- Single Phase 2/3 Adaptive Study Design -- Clinically Relevant, Objective Composite Endpoint - SAN DIEGO, CA / ACCESS Newswire / January 21, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, announced that the Co...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
207940
LISTED
KOE
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
News Preview
Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billionMaintained momentum through consistent operational performance and robust client demandStrengthened foundation for long-term growth through expanded manufacturing readiness and operational scaleINCHEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Samsung Biologics (KR...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
21.01.2026
ASBP
LISTED
NASDAQ
Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign
News Preview
New streamlined, mobile-optimized shopping experience, allows consumers to purchase BUZZ BOMB™ directly, access exclusive promotions and engage with the brand through educational and lifestyle content highlighting the benefits of sublingual delivery ESTERO, FL / ACCESS Newswire / January 21, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
21.01.2026
GRIN
LISTED
CSE
Grown Rogue Presenting at the 3rd Annual DealFlow Discovery Conference
News Preview
ATLANTIC CITY, NJ / ACCESS Newswire / January 21, 2026 / Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE:GRIN)(OTC:GRUSF), a flower-forward cannabis company combining craft values with disciplined execution, today announced that it will participate in the DealFlow Discovery Conference, taking place January 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
AVR
LISTED
NASDAQ
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
News Preview
MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the pricing of its...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
21.01.2026
XPHY
LISTED
CSE
BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)
News Preview
VANCOUVER, BC / ACCESS Newswire / January 21, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report final results from a preclinical pig study demonstrating that its proprietary needle-free, swallow-free sublingual oral dissolvable film (ODF) cladribine formulation for the...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
PACS
LISTED
NYSE
PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities
News Preview
PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds.
The facilities are located in the Kenai Peninsula region of Alaska and the Bois...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
AGL
LISTED
NYSE
Shareholder Rights Law Firm Robbins LLP Urges Agilon Health, Inc. Stockholders to Seek Information About Their Rights Against AGL
News Preview
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."
For more informa...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
IQV
LISTED
NYSE
IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 5, 2026. The IQVIA management team wil...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
VVOS
LISTED
NASDAQ
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
News Preview
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
MTD
LISTED
NYSE
METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors
News Preview
Mettler-Toledo International Inc. (NYSE: MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026.
Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer (“CFO”) at STERIS plc (NYSE: STE), a leading global healthcare and life science provider of product...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 5, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 first quarter ended December 31, 2026.
Webcast and Conference Call Details
Investors may access a live audio webcast on the Events and Presentat...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
ALC
LISTED
NYSE
Alcon Completes $750 Million Share Repurchase Program
News Preview
Alcon Inc., the global leader in eye care dedicated to helping people see brilliantly, today announced the completion of its $750 million share repurchase program, which commenced on April 1, 2025.
In aggregate, 9,301,877 registered shares were acquired on the SIX Swiss Exchange, representing 1.9% of the current share capital of Alcon Inc. The t...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
TPST
LISTED
NASDAQ
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders
News Preview
BRISBANE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company with a pipeline of targeted and immune-mediated therapeutics to fight cancer, today announced the record date of January 30, 2026 (the “Record Date”) for the distribution of warrants to purchase Tempest...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
CYH
LISTED
NYSE
Community Health Systems Announces Definitive Agreement to Sell Huntsville, Alabama, Hospital to Huntsville Hospital Health System
News Preview
Community Health Systems, Inc. (NYSE: CYH) announced today that a subsidiary of the Company has signed a definitive agreement to sell substantially all of the assets of 180-bed Crestwood Medical Center in Huntsville, Alabama, and its associated outpatient centers and practices, to Huntsville Hospital Health System for $450 million, subject to adju...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
HALO
LISTED
NASDAQ
Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update
News Preview
SAN DIEGO, Jan. 20, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced it will host an Investor Conference Call on Wednesday, January 28, 2026, at 5:30 am PT / 8:30 am ET.On the call, Dr. Helen Torley, President and Chief Executive Officer, and Nicole LaBrosse, Chief Financial Officer, will provide prelimi...
Themefolio
Profiler
Peergroup
© Newsfile
20.01.2026
JUMP
LISTED
TSX
LevelJump Enters into Cooperation Agreement with Concerned Shareholder; Announces Board Reconstitution
News Preview
Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic imaging services, today announced that it has entered into a cooperation agreement (the "Agreement") with Frank Teti.Under the terms of the Agreement, Le...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
VRTX
LISTED
NASDAQ
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
CMND
LISTED
NASDAQ
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
News Preview
Vancouver, Canada, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that it has filed its Annual...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
RPRX
LISTED
NASDAQ
Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
News Preview
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
CRVS
LISTED
NASDAQ
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
News Preview
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purcha...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
ERAS
LISTED
NASDAQ
Erasca Announces Proposed Public Offering of $150 Million of Common Stock
News Preview
SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 mill...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
BIOA
LISTED
NASDAQ
BioAge Announces Proposed Public Offering
News Preview
EMERYVILLE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced a proposed underwritten public offering in which it intends to offer...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
AVR
LISTED
NASDAQ
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
News Preview
MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced that it is offering...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
CYTK
LISTED
NASDAQ
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on January 15, 2026 it granted stock options to purchase an aggregate of 29,416 shares of common stock and 19,825 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 8 employees, wh...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
WAT
LISTED
NYSE
Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call
News Preview
MILFORD, Mass., Jan. 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2025 financial results conference call on Thursday, February 12th, 2026 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be avai...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
WAT
LISTED
NYSE
Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call
News Preview
MILFORD, Mass., Jan. 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2025 financial results conference call on Thursday, February 12th, 2026 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be avai...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
MAAT
LISTED
EURONEXT
MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis
News Preview
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, announced that the first patient has been randomized in the IMMUNOLIFE Phase 2 clinical...
Themefolio
Profiler
Peergroup
© ActuNews
20.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma Announces its 2026 Financial Calendar
News Preview
Lyon, France – January 20, 2026, 18:00 p.m. CET – THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces its financial communication agenda for. Each publication will be released after Euronext market closing, unless otherwise specified . These dates are given as...
Themefolio
Profiler
Peergroup
© ActuNews
20.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma publie son agenda financier 2026
News Preview
THX Pharma publie son agenda financier 2026
Lyon, France – 20 janvier 2026, 18h CET – THX Pharma (Theranexus), société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui son agenda financier 2026. Les publications auront lieu après la clôture des march&eacut...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
TIVC
LISTED
NASDAQ
Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference
News Preview
Presentation will Cover Recent Corporate Milestones Including Acceleration of Manufacturing Readiness for Entolimod™ FREMONT, CA / ACCESS Newswire / January 20, 2026 / Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage immunotherapeutics company, today announced that its CEO will provide a corporate update focused on recent developm...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Bilan semestriel du contrat de liquidité avec Invest Securities...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
OSE
LISTED
EURONEXT
Half-Year Report on Liquidity Contract with Invest Securities
News Preview
Half-Year Report on Liquidity Contract with Invest Securities...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
AYTU
LISTED
NASDAQ
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
News Preview
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today provided a summary of the Company's Investor Day, held t...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
COSM
LISTED
NASDAQ
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
News Preview
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued operational growth and infrastructure expansion at Cosmofarm, its pharmaceutical distribution subsidiary in Greece....
Themefolio
Profiler
Peergroup
© Newsfile
20.01.2026
PHIO
LISTED
NASDAQ
Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial
News Preview
Pathology data indicate 70% overall response rate for squamous cell carcinomas: 100% clearance in 10 out of 14 responders Favorable safety and tolerability at all dose escalations King of Prussia, Pennsylvania--(Newsfile Corp. - January 20, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company develop...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
MAIA
LISTED
XASE
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
News Preview
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
ABT
LISTED
NYSE
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
News Preview
Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™, is designed with dual-energy to treat atrial fibrillation patients with the most challenging casesIt can deliver both radiofrequency energy and pulsed field ablation (PFA) energy during procedures to target and treat an irregular heart rhythmThe availability of TactiFlex Duo in Europe add...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
TTNP
LISTED
NASDAQ
Early & Accessible Investing
News Preview
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 20, 2026 / The very concept of an "investment" is being redefined. High barriers to entry are being dismantled by technology, creating a more democratized landscape. This trend toward fractionalization allows for greater agility in how assets are managed and deployed.Recognizing this shi...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
LIVN
LISTED
NASDAQ
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2025 results on Wed., Feb. 25, 2026, at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its fourth-quarter and full-year 2025 results prior to the call.
The audiocast will b...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
GSK
LISTED
NYSE
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
News Preview
GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN).
GSK previously sough...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
THAR
LISTED
NASDAQ
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering
News Preview
NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the pricing of a $55 million registered offering.
Tharimmune, Inc. operates a differentiated digital asset treasury str...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
MYND
LISTED
CSE
Promethean ActivSuite Expands Compatibility with ChromeOS Integration
News Preview
ChromeOS integration delivers seamless, cross-platform access to Promethean's interactive teaching tools for educators worldwideSEATTLE, Jan. 20, 2026 /PRNewswire/ -- Promethean, a global education and workplace technology company and a brand of Mynd.ai (NYSE American: MYND), today announced a major expansion of its flagship Promethean ActivSuite®...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
NDSN
LISTED
NASDAQ
Nordson EFD Takes Assembly Automation to Center Stage at MD&M West, February 3 – 5, 2026
News Preview
Nordson EFD, a Nordson company (NASDAQ: NDSN), announced today it will spotlight multiple medical assembly automation applications at MD&M West 2026, Anaheim Convention Center, Anaheim, CA from February 3-5, 2026. In Booth 2915, show attendees will get a close look at Nordson EFD’s comprehensive product line of automated, semi-automated and ma...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
VNRX
LISTED
XASE
Volition Continues to Extend Access to Nu.Q® Vet Cancer Test
News Preview
HENDERSON, Nev., Jan. 20, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the appointment of two new centralized laboratory providers of its Nu.Q® Vet Cancer test in the U.S. and Asia, further expanding access to its canine cancer early detection tool.
Midwest Veterinary L...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
CAPR
LISTED
NASDAQ
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
News Preview
SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today provided a regulatory update regarding its Biologics License Application (BLA) for Deramiocel, the Company’s investigational first-in-cla...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
QCLS
LISTED
NASDAQ
Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors
News Preview
New York, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C Technologies” or “the Company”), a pioneer of quantum-class computing at the speed of light, today announced the appointment of Chelsea Voss to its Board of Directors....
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
PGEN
LISTED
NASDAQ
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
News Preview
Independent, expert-led consensus paper, sponsored by the Recurrent Respiratory Papillomatosis Foundation, reflects the recommendation of 16 leading physicians in the field of RRPConsensus paper recommends PAPZIMEOS as the new standard of care first-line treatment for adults with RRPGERMANTOWN, Md., Jan. 20, 2026 /PRNewswire/ -- Precigen, Inc. (Na...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
